Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $50.2463 (1.24%) ($49.3004 - $50.4515) on Wed. Mar. 16, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.36% (three month average) | RSI | 51 | Latest Price | $50.2463(1.24%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) VYM(49%) IVE(47%) IBB(46%) IWD(46%) | Factors Impacting ABBV price | ABBV will decline at least -1.18% in a week (0% probabilities). VIXM(-19%) TLT(-14%) UUP(-10%) IGOV(-3%) IPO(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.18% (StdDev 2.36%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $50.52(-0.54%) | 10 Day Moving Average | $50.27(-0.05%) | 20 Day Moving Average | $49.84(0.82%) | To recent high | -4.8% | To recent low | 10% | Market Cap | $88.649b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |